Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Pediatric Condition Falsification Misdiagnosed by Misjudged Weight Growth from the Curve of Measured Weights.

van Gemert MJC, Vlaming M, Osinga E, Bruijninckx CMA, Neumann HAM, Sauer PJJ.

Am J Case Rep. 2018 Jun 27;19:752-756. doi: 10.12659/AJCR.908770.

2.

Predicting cardiac safety using human induced pluripotent stem cell-derived cardiomyocytes combined with multi-electrode array (MEA) technology: A conference report.

Mulder P, de Korte T, Dragicevic E, Kraushaar U, Printemps R, Vlaming MLH, Braam SR, Valentin JP.

J Pharmacol Toxicol Methods. 2018 May - Jun;91:36-42. doi: 10.1016/j.vascn.2018.01.003. Epub 2018 Feb 4. Review.

PMID:
29355722
3.

Feasibility of SPECT-CT Imaging to Study the Pharmacokinetics of Antisense Oligonucleotides in a Mouse Model of Duchenne Muscular Dystrophy.

van de Steeg E, Läppchen T, Aguilera B, Jansen HT, Muilwijk D, Vermue R, van der Hoorn JW, Donato K, Rossin R, de Visser PC, Vlaming MLH.

Nucleic Acid Ther. 2017 Aug;27(4):221-231. doi: 10.1089/nat.2016.0649. Epub 2017 Apr 18.

PMID:
28418733
4.

PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.

Vlaming ML, Läppchen T, Jansen HT, Kivits S, van Driel A, van de Steeg E, van der Hoorn JW, Sio CF, Steinbach OC, DeGroot J.

Nucl Med Biol. 2015 Nov;42(11):833-41. doi: 10.1016/j.nucmedbio.2015.07.004. Epub 2015 Jul 15.

PMID:
26264927
5.

To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.

Bosgra S, Vlaming ML, Vaes WH.

Clin Pharmacokinet. 2016 Jan;55(1):1-15. doi: 10.1007/s40262-015-0308-9.

PMID:
26242381
6.

Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages.

Vlaming ML, van Duijn E, Dillingh MR, Brands R, Windhorst AD, Hendrikse NH, Bosgra S, Burggraaf J, de Koning MC, Fidder A, Mocking JA, Sandman H, de Ligt RA, Fabriek BO, Pasman WJ, Seinen W, Alves T, Carrondo M, Peixoto C, Peeters PA, Vaes WH.

Clin Pharmacol Ther. 2015 Aug;98(2):196-204. doi: 10.1002/cpt.131. Epub 2015 May 19.

PMID:
25869840
7.

Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3.

van de Steeg E, Venhorst J, Jansen HT, Nooijen IH, DeGroot J, Wortelboer HM, Vlaming ML.

Eur J Pharm Sci. 2015 Apr 5;70:29-36. doi: 10.1016/j.ejps.2015.01.004. Epub 2015 Jan 17.

PMID:
25603031
8.

Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.

Bosgra S, van de Steeg E, Vlaming ML, Verhoeckx KC, Huisman MT, Verwei M, Wortelboer HM.

Eur J Pharm Sci. 2014 Dec 18;65:156-66. doi: 10.1016/j.ejps.2014.09.007. Epub 2014 Sep 28.

PMID:
25261337
9.

Automated screening for high-frequency hearing loss.

Vlaming MS, MacKinnon RC, Jansen M, Moore DR.

Ear Hear. 2014 Nov-Dec;35(6):667-79. doi: 10.1097/AUD.0000000000000073.

10.

PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model.

de Paula Faria D, Vlaming ML, Copray SC, Tielen F, Anthonijsz HJ, Sijbesma JW, Buchpiguel CA, Dierckx RA, van der Hoorn JW, de Vries EF.

J Nucl Med. 2014 Aug;55(8):1330-5. doi: 10.2967/jnumed.114.137216. Epub 2014 Jun 9.

11.

Bcrp1;Mdr1a/b;Mrp2 combination knockout mice: altered disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) and its genotoxic metabolites.

Vlaming ML, Teunissen SF, van de Steeg E, van Esch A, Wagenaar E, Brunsveld L, de Greef TF, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.

Mol Pharmacol. 2014 Mar;85(3):520-30. doi: 10.1124/mol.113.088823. Epub 2013 Dec 13.

12.

Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.

van de Steeg E, Greupink R, Schreurs M, Nooijen IH, Verhoeckx KC, Hanemaaijer R, Ripken D, Monshouwer M, Vlaming ML, DeGroot J, Verwei M, Russel FG, Huisman MT, Wortelboer HM.

Drug Metab Dispos. 2013 Mar;41(3):592-601. doi: 10.1124/dmd.112.049023. Epub 2012 Dec 17.

13.

Automated synthesis of [18F]gefitinib on a modular system.

Läppchen T, Vlaming ML, Custers E, Lub J, Sio CF, DeGroot J, Steinbach OC.

Appl Radiat Isot. 2012 Jan;70(1):205-9. doi: 10.1016/j.apradiso.2011.09.005. Epub 2011 Sep 17.

PMID:
21975107
14.

Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.

Vlaming ML, van Esch A, van de Steeg E, Pala Z, Wagenaar E, van Tellingen O, Schinkel AH.

Drug Metab Dispos. 2011 Aug;39(8):1338-44. doi: 10.1124/dmd.111.038794. Epub 2011 May 12.

15.

Development and analysis of an International Speech Test Signal (ISTS).

Holube I, Fredelake S, Vlaming M, Kollmeier B.

Int J Audiol. 2010 Dec;49(12):891-903. doi: 10.3109/14992027.2010.506889.

PMID:
21070124
16.

Standard audiograms for the IEC 60118-15 measurement procedure.

Bisgaard N, Vlaming MS, Dahlquist M.

Trends Amplif. 2010 Jun;14(2):113-20. doi: 10.1177/1084713810379609.

17.
18.

Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.

de Waart DR, Häusler S, Vlaming ML, Kunne C, Hänggi E, Gruss HJ, Oude Elferink RP, Stieger B.

J Pharmacol Exp Ther. 2010 Jul;334(1):78-86. doi: 10.1124/jpet.110.166991. Epub 2010 Apr 13.

19.

P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide.

Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH.

Clin Cancer Res. 2010 Jan 1;16(1):130-40. doi: 10.1158/1078-0432.CCR-09-1321. Epub 2009 Dec 22.

20.

Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo.

Vlaming ML, van Esch A, Pala Z, Wagenaar E, van de Wetering K, van Tellingen O, Schinkel AH.

Mol Cancer Ther. 2009 Dec;8(12):3350-9. doi: 10.1158/1535-7163.MCT-09-0668.

21.

Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice.

Lagas JS, Vlaming ML, Schinkel AH.

Mol Interv. 2009 Jun;9(3):136-45. doi: 10.1124/mi.9.3.7. Review.

PMID:
19592674
22.

Complex pharmacokinetic behavior of ezetimibe depends on abcc2, abcc3, and abcg2.

de Waart DR, Vlaming ML, Kunne C, Schinkel AH, Oude Elferink RP.

Drug Metab Dispos. 2009 Aug;37(8):1698-702. doi: 10.1124/dmd.108.026146. Epub 2009 May 14.

23.

Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo.

Vlaming ML, Pala Z, van Esch A, Wagenaar E, de Waart DR, van de Wetering K, van der Kruijssen CM, Oude Elferink RP, van Tellingen O, Schinkel AH.

Clin Cancer Res. 2009 May 1;15(9):3084-93. doi: 10.1158/1078-0432.CCR-08-2940. Epub 2009 Apr 21.

24.

The influence of age, hearing, and working memory on the speech comprehension benefit derived from an automatic speech recognition system.

Zekveld AA, Kramer SE, Kessens JM, Vlaming MS, Houtgast T.

Ear Hear. 2009 Apr;30(2):262-72. doi: 10.1097/AUD.0b013e3181987063.

PMID:
19194286
25.

User evaluation of a communication system that automatically generates captions to improve telephone communication.

Zekveld AA, Kramer SE, Kessens JM, Vlaming MS, Houtgast T.

Trends Amplif. 2009 Mar;13(1):44-68. doi: 10.1177/1084713808330207. Epub 2009 Jan 5.

26.

Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.

Vlaming ML, Lagas JS, Schinkel AH.

Adv Drug Deliv Rev. 2009 Jan 31;61(1):14-25. doi: 10.1016/j.addr.2008.08.007. Epub 2008 Dec 7. Review.

PMID:
19118589
27.

Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite.

Sparidans RW, Vlaming ML, Lagas JS, Schinkel AH, Schellens JH, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):269-76. doi: 10.1016/j.jchromb.2008.12.026. Epub 2008 Dec 24.

PMID:
19117812
28.

Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.

Vlaming ML, Pala Z, van Esch A, Wagenaar E, van Tellingen O, de Waart DR, Oude Elferink RP, van de Wetering K, Schinkel AH.

Clin Cancer Res. 2008 Dec 15;14(24):8152-60. doi: 10.1158/1078-0432.CCR-08-1609.

29.

The benefit obtained from visually displayed text from an automatic speech recognizer during listening to speech presented in noise.

Zekveld AA, Kramer SE, Kessens JM, Vlaming MS, Houtgast T.

Ear Hear. 2008 Dec;29(6):838-52. doi: 10.1097/AUD.0b013e31818005bd.

PMID:
18633325
30.

Audiovisual perception of speech in noise and masked written text.

Zekveld AA, Kramer SE, Vlaming MS, Houtgast T.

Ear Hear. 2008 Jan;29(1):99-111.

PMID:
18091101
31.

Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides.

van de Wetering K, Zelcer N, Kuil A, Feddema W, Hillebrand M, Vlaming ML, Schinkel AH, Beijnen JH, Borst P.

Mol Pharmacol. 2007 Aug;72(2):387-94. Epub 2007 May 7.

32.

Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX.

Jonker JW, Musters S, Vlaming ML, Plösch T, Gooijert KE, Hillebrand MJ, Rosing H, Beijnen JH, Verkade HJ, Schinkel AH.

Am J Physiol Cell Physiol. 2007 Jun;292(6):C2204-12. Epub 2007 Feb 21.

33.

Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics.

Lagas JS, Vlaming ML, van Tellingen O, Wagenaar E, Jansen RS, Rosing H, Beijnen JH, Schinkel AH.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6125-32.

34.

Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice.

Vlaming ML, Mohrmann K, Wagenaar E, de Waart DR, Elferink RP, Lagas JS, van Tellingen O, Vainchtein LD, Rosing H, Beijnen JH, Schellens JH, Schinkel AH.

J Pharmacol Exp Ther. 2006 Jul;318(1):319-27. Epub 2006 Apr 12.

35.

Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier.

Soontornmalai A, Vlaming ML, Fritschy JM.

Neuroscience. 2006;138(1):159-69. Epub 2005 Dec 19.

PMID:
16361063
36.

A method to induce swapped binaural hearing.

Hofman PM, Vlaming MS, Termeer PJ, Van Opstal AJ.

J Neurosci Methods. 2002 Jan 30;113(2):167-79.

PMID:
11772438
37.

User tests with the multi-mode compression architecture.

Vlaming MS, Termeer PJ, Donkers EH.

Scand Audiol Suppl. 2001;(52):76-8.

PMID:
11318490
38.

[Specialists and nurses].

Vlaming M.

TVZ. 1997 Sep 6;107(15-16):477. Dutch. No abstract available.

PMID:
9444263
39.

Laser interferometry with human temporal bones.

Feenstra L, Vlaming MS.

Adv Otorhinolaryngol. 1987;37:36-8. No abstract available.

PMID:
3673817
40.

Studies on the mechanics of the reconstructed human middle ear.

Vlaming MS, Feenstra L.

Clin Otolaryngol Allied Sci. 1986 Dec;11(6):411-22.

PMID:
3815866
41.

Studies on the mechanics of the normal human middle ear.

Vlaming MS, Feenstra L.

Clin Otolaryngol Allied Sci. 1986 Oct;11(5):353-63.

PMID:
3536194
42.

Directional hearing in the grassfrog (Rana temporaria L.). II. Acoustics and modelling of the auditory periphery.

Aertsen AM, Vlaming MS, Eggermont JJ, Johannesma PI.

Hear Res. 1986;21(1):17-40.

PMID:
3485627
43.

Directional hearing in the grass frog (Rana temporaria L.): I. Mechanical vibrations of tympanic membrane.

Vlaming MS, Aertsen AM, Epping WJ.

Hear Res. 1984 May;14(2):191-201.

PMID:
6611330
44.

Laser--Doppler velocity meter applied to tympanic membrane vibrations in cat.

Buunen TJ, Vlaming MS.

J Acoust Soc Am. 1981 Mar;69(3):744-50.

PMID:
7240554
45.

Digital A-scan ultrasonography used to measure ocular distances.

van der Heijde GL, Meinema AJ, Vlaming MS.

Am J Ophthalmol. 1977 Feb;83(2):276-7.

PMID:
836670

Supplemental Content

Loading ...
Support Center